Prof. Yvan Vandenplas
Author

Yvan Vandenplas

Professor

University Hospital Brussels (UZ Brussel) (Head of the Pediatric Hospital, the "KidZ Health Castle", Chair of Pediatrics since 1994)

Medical studies at the Vrije Universiteit Brussel. 
Defended his Ph.D. thesis on "Esophageal pH monitoring for Gastro-Esophageal Reflux in Infants and Children" in 1991. 

Founder and current consultant at "KidZ Health Castle", at the University Hospital Brussels (UZ Brussel) of the Vrije Universiteit Brussel. From 1994 - 2021 he was the Chair of Pediatrics at the same Institution.

Main interests are functional gastro-intestinal disorders such as gastro-esophageal reflux, colic and constipation, infant nutrition, focusing on probiotics, prebiotics and cow's milk protein allergy.

Authored over 500 publications listed in Pubmed and presented over 1000 talks at diverse international meetings

Save (for later) 15 Articles 26 Videos 16 Publications

Articles from this author

Default publication
Do Probiotics Really Need to Be “Alive”?

Do Probiotics Really Need to Be “Alive”?

Yvan Vandenplas
Default publication
Gut discomfort in toddlers: can nutrition bring a solution?

Gut discomfort in toddlers: can nutrition bring a solution?

Yvan Vandenplas
Default publication
HMOs boost the immune system

HMOs boost the immune system

Yvan Vandenplas
Default publication
Functional gastrointestinal disorders in infants : relevance in daily practice

Functional gastrointestinal disorders in infants : relevance in daily practice

Yvan Vandenplas

Videos from this author

Navigating the Cow’s Milk Allergy Journey From Diagnosis to Nutritional Optimization.png
Navigating the Cow’s Milk Allergy Journey: From Diagnosis to Nutritional Optimization

Navigating the Cow’s Milk Allergy Journey: From Diagnosis to Nutritional Optimization

Co-Authored by 4 Experts >5 minutes
How do HMO modulate the immune system in infants with CMPA_ emerging evidence and clinical implications
How do HMOs modulate the immune system in infants with CMPA: Emerging evidence and clinical implications

How do HMOs modulate the immune system in infants with CMPA: Emerging evidence and clinical implications

Co-Authored by 4 Experts >5 minutes
Can CoMiSS™ Be Improved
Can CoMiSS™ Be Improved?

Can CoMiSS™ Be Improved?

Yvan Vandenplas >5 minutes
Prof Yvan's talk
The clinical relevance of HMOs in infants with CMPA

The clinical relevance of HMOs in infants with CMPA

Yvan Vandenplas

Publications from this author

Default publication
Safety and efficacy of a probiotic-containing infant formula supplemented with 2’-fucosyllactose: a double-blind randomized controlled trial

Safety and efficacy of a probiotic-containing infant formula supplemented with 2’-fucosyllactose: a double-blind randomized controlled trial

Co-Authored by 12 Experts
Default publication
Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow’s Milk Protein Allergy: A Randomized, Multi-Center Trial

Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow’s Milk Protein Allergy: A Randomized, Multi-Center Trial

Co-Authored by 12 Experts
The Nest 46: Functional Gastrointestinal disorders in Infants (publications)
The Nest 46: Functional Gastrointestinal disorders in Infants

The Nest 46: Functional Gastrointestinal disorders in Infants

Co-Authored by 4 Experts
HMOs: A window of opportunity or a weapon in strengthening immunity (publications)
HMOs: A window of opportunity or a weapon in strengthening immunity

HMOs: A window of opportunity or a weapon in strengthening immunity

Co-Authored by 5 Experts